Health Savings and Affordability for Fertility Act
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
This bill amends the Internal Revenue Code to allow expenses related to fertility treatments to be deducted as medical expenses within Health Savings Accounts (HSAs). Specifically, it expands the definition of ‘medical expenses’ to include procedures like egg and sperm preservation, artificial insemination, in vitro fertilization, and gamete donation. The changes will apply to expenses incurred after the bill’s enactment.
Key provisions
- Fertility treatments are now considered medical expenses for HSA purposes.
- The definition of ‘fertility treatment’ is expanded to include oocyte/sperm preservation, artificial insemination, and assisted reproductive technology.
- Gamete donation expenses are included as medical expenses.
- Medications prescribed for fertility are also included.
Who is affected
- Individuals seeking fertility treatments
- Health Savings Account holders
- Fertility clinics and providers
- Gamete donors
Notable changes
- Expands the definition of ‘medical expense’ under the Internal Revenue Code.
- Provides tax benefits for fertility treatment costs through HSAs.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsor
Cosponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours